- Home
- CMPX vs EM Comparison
CMPX vs EM Comparison
Compare CMPX & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- EM
- Stock Information
- Founded
- CMPX 2014
- EM 2017
- Country
- CMPX United States
- EM China
- Employees
- CMPX N/A
- EM N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- EM Other Consumer Services
- Sector
- CMPX Health Care
- EM Consumer Discretionary
- Exchange
- CMPX Nasdaq
- EM Nasdaq
- Market Cap
- CMPX 291.8M
- EM 281.5M
- IPO Year
- CMPX N/A
- EM 2021
- Fundamental
- Price
- CMPX $2.61
- EM $1.14
- Analyst Decision
- CMPX Strong Buy
- EM Hold
- Analyst Count
- CMPX 9
- EM 1
- Target Price
- CMPX $12.67
- EM $1.25
- AVG Volume (30 Days)
- CMPX 946.0K
- EM 73.0K
- Earning Date
- CMPX 08-11-2025
- EM 08-21-2025
- Dividend Yield
- CMPX N/A
- EM N/A
- EPS Growth
- CMPX N/A
- EM N/A
- EPS
- CMPX N/A
- EM N/A
- Revenue
- CMPX $850,000.00
- EM $259,541,587.00
- Revenue This Year
- CMPX N/A
- EM $3.30
- Revenue Next Year
- CMPX N/A
- EM $5.26
- P/E Ratio
- CMPX N/A
- EM N/A
- Revenue Growth
- CMPX N/A
- EM N/A
- 52 Week Low
- CMPX $0.77
- EM $0.50
- 52 Week High
- CMPX $4.08
- EM $1.17
- Technical
- Relative Strength Index (RSI)
- CMPX 60.92
- EM 65.51
- Support Level
- CMPX $2.52
- EM $1.13
- Resistance Level
- CMPX $2.71
- EM $1.17
- Average True Range (ATR)
- CMPX 0.17
- EM 0.03
- MACD
- CMPX 0.00
- EM 0.00
- Stochastic Oscillator
- CMPX 68.64
- EM 77.78
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.